HCTI · Healthcare Triangle, Inc. · Metrics
Market Cap
$11.65M
Shares
14.97M
Volume · Oct 5
929.58K
Avg daily vol (3M)
2.29M
HCTI metrics
55 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$0.73
Market cap
$11.65M
Price action
20 metricsPrice change (1W)
-6.8%
Price change (30D)
-8.0%
Price change (3M)
-61.6%
Price change (6M)
-70.6%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
119.2%
Annualized volatility (3M)
144.2%
Beta
1.8
RSI (14D)
42.3
Price vs SMA 50
-25.6%
Price vs SMA 200
—
Avg volume (3M)
2.29M
Relative volume
0.3
Average dollar volume
$2.63M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
14.97M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.9×
reciprocal yield 110.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 220.4%
P / book
0.2
reciprocal yield 421.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-146.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.7×
reciprocal yield 145.6%
EV / revenue historical average (5Y)
0.7×
reciprocal yield 145.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
-57.4%
Trailing 12 months
Net margin
-66.3%
Gross profit (TTM)
$1.24B
Operating profit (TTM)
−$14.73M
Net income (TTM)
−$17.02M
Trailing 12 months
Diluted EPS (TTM)
$-125.49
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+158.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$25.68M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+7,083.2%
Year over year · more shares
Revenue CAGR (3Y)
-32.9%
Revenue CAGR (5Y)
-15.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-34.7%
Return on assets
-23.1%
Debt / equity
0.3
Current ratio
0.6
EBITDA (TTM)
−$12.69M
Free cash flow (TTM)
—
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$11.64M
Latest balance sheet
Cash & equivalents
$1.91M
Total assets
$73.64M
Total debt
$13.54M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$16.03M
Capital expenditures (TTM)
—
R&D (TTM)
$473,000
SG&A (TTM)
—
Stock compensation (TTM)
$451,000
R&D / revenue
1.8%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
8
13F filer change QoQ
-2
Institutional ownership
0.3%
Short interest
3 metricsShort interest
3.2%
Latest settlement · 1.4 days to cover
Days to cover
1.4d
Short-squeeze score
53 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—